Dengue viruses replicate readily in cultures of peripheral blood leukocytes (PBL) prepared from dengue-immune primate donors but poorly or not at all in PBL from a nonimmune host (10, 11, (18) (19) (20) . In preliminary studies, addition of dengue virus to dengue-immune rhesus monkey PBL resulted in lymphoblast transformation as evidenced by increased incorporation of tritiated thymidine (10) . In parallel experiments, phytohemagglutinin (PHA)-treated nonimmune monkey PBL supported virus growth; untreated controls did not.
On the basis of these preliminary observations, we hypothesized that specifically committed lymphocytes transformed to lymphoblasts by dengue virus are inherently permissive to dengue infection (10) . We now believe that dengue virus replication in immune PBL and in PHA-treated nonimmune PBL are separate and distinct phenomena. Subsequent experiments have shown that when mononuclear phagocytes were selectively destroyed by silica (E.J. O'Rourke et al., J. Immunol. Methods, in press), dengue virus replication was suppressed in dengue-immune human PBL cultures (unpublished data) . This provides evidence that mononuclear phagocytes can support dengue virus replication in the absence of mitogen stimulation. However, since mitogens primarily affect lymphocytes, it is possible that dengue virus replication in PHAtreated PBL takes place in lymphocytes.
The present study presents further observations on the infection and replication of dengue-2 virus (D2V) in mitogen-treated monkey PBL.
MATERIALS AND METHODS
Virus. D2V (16681) (12) was prepared in LLC-MK2 cell cultures as previously described (17) .
Rhesus monkey leukocyte donors. Juvenile and adult female rhesus monkeys (Macaca mulatta) from commercial sources were housed individually and fed commercial feed supplemented with fresh fruit and water ad libitum. They were without hemagglutination inhibition antibodies to flaviviruses (dengue-1, -2, -3, -4, Japanese encephalitis, and Zika) or neutralizing antibodies of dengue virus types 1, 2, 3, or 4 when selected for the study. These or similar monkeys were subsequently infected with dengue virus types 1, 2, 3, or 4 by subcutaneous inoculation (17) Selective destruction of mononuclear phagocytes. A suspension of particulate silica (Dorentrop quartz <5 ,um in diameter) (2) containing 1.0 mg/ml in RPMI 1640 complete medium was dispersed by sonic treatment (O'Rourke et al., J. Immunol. Methods, in press), and 0.1 ml was added to PHA-treated and control cultures of PBL from nonimmune monkeys at the same time as D2V. On culture days 1 through 5, latex beads were added to replicate tubes as described, and samples were centrifuged onto slides in a cytospin (Shandon Southern Instruments, Sewickley, Pa.). The preparations were air dried, fixed in cold (-20°C) acetone for 10 min, and stained with a fluorescein-tagged specific monkey anti-D2V globulin purified by diethylaminoethyl-cellulose chromatography (9) . The slides were examined with the Zeiss microscope described above fitted with a KP-490 exciter filter and an FT 510 beam splitter. Cells with specific cytoplasmic fluorescence were observed under phase contrast to determine the presence of phagocytized latex particles. The remainder of each culture was stored at -70°C for virus assay.
Virus assay. Infected cell cultures (in triplicate) were frozen at -70°C on days 1 through 6 after addition of D2V. A sample of the D2V inoculum in each experiment was similarly frozen at -70°C and stored until titrated. Virus was assayed by standard plaque assay in LLC-MK2 cells (12) or in porcine kidney (PS) cells (14) . The minimum virus titer detectable was 1.0 log1o plaque-forming unit/ml of culture. Half the minimum value (0.5) was assigned for samples without plaques.
Assay for infected cells. The number of infected cells was determined by an infectious-center assay similar to that described by Bloom et (Table 3) .
Only an occasional cell with specific dengue antigen was seen by fluorescent microscopy in cultures of untreated nonimmune monkey PBL incubated for (Table 5) .
Replication of D2V in mitogen-treated PBL from immune monkeys. Treatment of PBL from dengue-immune monkeys with PHA, PWM, or SLO did not significantly enhance or inhibit virus production. Cells treated with ConA produced less virus, but the results were not significant at the 5% level (Table 6) . DISCUSSION The present study confirms our original observations (10) that PHA treatment of nonimmune monkey PBL renders them permissive to D2V. The number and function of mononuclear phagocytes were not altered by PHA treatment, but it cannot be concluded that PHA had no effect on them. There is no evidence that PHA is a mitogen for these cells, but it may induce less dramatic metabolic changes (13). However, silica, which is cytotoxic for mononuclear phagocytes (1) but does not affect lymphocytes (O'Rourke et al., J. Immunol. Methods, in press), did not significantly reduce D2V replication in PHA-treated cultures. Therefore, PHA treatment presumably increased permissiveness by action on some cell other than the mononuclear phagocyte. This observation is consistent with the hypothesis previously advanced that dengue antigen transforms specifically sensitized lymphocytes, and these serve as the permissive host cells.
Other data, however, suggest that this mechanism is not operating in immune monkey PBL or in noninmune PBL in the presence of nonneutralizing anti-dengue serum (lla (19) and measles virus-infected human PBL (20) . Yellow fever virus, which resembles dengue virus in many ways, also replicates in untreated human monocytes; treatment of PBL cultures with PHA resulted in virus replication in lymphocytes but no enhancement of replication in monocytes (22) . In PHA-treated human PBL, (23) .
The monkey lymphocyte that supports D2V replication after PHA treatment has not been identified. The specific lymphocyte subpopulation responding to PHA stimulation appears to differ from species to species, and no data are available for rhesus monkeys. In the human system, for example, PWM rather than PHA is reported to enhance D2V permissiveness of PBL (21) . Preliminary evidence suggests that different cells or different mechanisms are operating in the monkey and human PBL-mitogen-dengue system.
The failure of mitogens other than PHA to enhance or induce permissiveness to D2V in nonimmune monkey PBL suggests that transformation per se may not be the event that confers permissiveness. Specific alteration of the lymphocyte membrane by PHA may allow the virus to adsorb to and enter the cell. This membrane change must be stable since cells treated with PHA for 3 days before adding virus are essentially as permissive as those treated for only 2 h before D2V infection. The initial effect of PHA on the cell is to modulate membrane phospholipids (10, 14) . Thus, a reasonable hypothesis is that PHA uncovers or induces the formation of membrane receptors capable of interacting with D2V, thereby allowing infection to occur. In other systems, enhanced virus replication in PHA-treated PBL also is due, at least partly, to an increase in the number of cells that become infected (5, 23), presumably for similar reasons.
We have no explanation for the inability of PWM, ConA, and SLO to enhance D2V replication in monkey PBL. The initial action of these mitogens is also on the cell membrane, but different receptors are involved, and the subsequent alteration of membrane structure or physiology probably differs. There is no evidence that any of these mitogens except possibly ConA interferes with virus replication in permissive dengue-immune PBL (Table 6 ), ruling out a toxic effect or the production of virus-inhibitory substances by the mitogen-stimulated cells.
PHA treatment resulted in a more than 10-fold increase in D2V yield 3 to 6 days postinfection, but the effect of PHA on internalization of virus (as measured by the infectious-center assay) resulted in only a three-to fourfold increase in the number of infected cells. These data suggest not only that PHA increases the number of cells capable of internalizing the virus, but also that replication may depend upon the cytoplasmic changes accompanying cell transformation. The increased virus yield in PHAtreated cultures may also depend to some extent upon secondary or tertiary spread of virus to cells transformed during the culture period.
